Kidney disease drug trial seeks clues in urine
Knowledge-focused
Recruiting now
This study aims to understand how a drug called Empagliflozin affects the body's handling of important minerals like calcium and magnesium in people with an inherited form of kidney disease. Forty participants will take the drug or a placebo for two weeks while researchers measur…
Phase: PHASE2 • Sponsor: Cantonal Hospital Graubuenden • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC